Piñeiro Aguín Zenaida, León Vintró Xavier, García Lorenzo Jacinto, Sancho Francisco J, López Pousa Antonio, Quer Agustí Miquel
Servicio de Otorrinolaringología, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
Acta Otorrinolaringol Esp. 2011 Nov-Dec;62(6):436-42. doi: 10.1016/j.otorri.2011.05.005. Epub 2011 Aug 5.
Head and neck sarcomas are a heterogeneous group of malignant tumours that vary greatly in clinical presentation, with different histopathological and biological characteristics.
This was a retrospective study of patients with sarcoma located in the head and neck treated in our centre over a period of 25 years.
During the study period, a total of 25 patients were diagnosed with sarcomas in the head and neck, accounting for 0.5% of all malignancies at this level. The most common treatments included surgical resection of the tumour, often supplemented with radiotherapy and/or adjuvant chemotherapy. The final local control, including the salvage, was 52%, with an adjusted survival of 51% at 5 years and 32% at 12 years.
Surgical treatment of patients with head and neck sarcomas achieves acceptable results of local control and survival.